<DOC>
	<DOC>NCT02522871</DOC>
	<brief_summary>A prospective, phased-pivotal, international randomized trial to evaluate the effectiveness of the OCS™ Liver to preserve and assess donor livers intended for transplantation.</brief_summary>
	<brief_title>TransMedics (OCS) Liver Trial: Preserving and Assessing Donor Livers for Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Registered male or female primary Liver transplant candidate Age ≥18 years old Signed: 1) written informed consent document and 2) authorization to use and disclose protected health information Acute, fulminant liver failure Prior solid organ or bone marrow transplant Chronic use of hemodialysis or diagnosis of chronic renal failure, defined as chronic serum creatinine of &gt;3 mg/dl for &gt;2 weeks and/or requiring hemodialysis Multiorgan transplant Ventilator dependent Dependent on &gt; 1 IV inotrope to maintain hemodynamics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>